Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Neurofibromatosis Type 1 (NF1), a genetic condition that causes tumours to grow on nerve tissue
- People who have been diagnosed with Neurofibromatosis Type 2 (NF2), a condition that causes non-cancerous tumours to grow on the nerves
- People who have been diagnosed with Schwannomatosis, a condition that causes non-cancerous tumours called schwannomas to develop on nerves
Who may not be able to join:
- People who do not complete the account registration process required to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kate Kelts, B.S.N., The Children's Tumor Foundation
Phone: 646-738-8567
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To create a natural history of NF1, NF2, and schwannomatosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.